After few days of intense immunoglobulin (Ig) secretion, most plasma cells undergo apoptosis, thus ending the humoral immune response. We asked whether intrinsic factors link plasma cell lifespan to Ig secretion. Here we show that in the late phases of plasmacytic differentiation, when antibody production becomes maximal, proteasomal activity decreases. The excessive load for the reduced proteolytic capacity correlates with accumulation of polyubiquitinated proteins, stabilization of endogenous proteasomal substrates (including Xbp1s, IkBalpha, and Bax), onset of apoptosis, and sensitization to proteasome inhibitors (PI). These events can be reproduced by expressing Ig-mu chain in nonlymphoid cells. Our results suggest that a developmental program links plasma cell death to protein production, and help explaining the peculiar sensitivity of normal and malignant plasma cells to PI.

Progressively impaired proteasomal capacity during terminal plasma cell differentiation

FRA, Annamaria;
2006-01-01

Abstract

After few days of intense immunoglobulin (Ig) secretion, most plasma cells undergo apoptosis, thus ending the humoral immune response. We asked whether intrinsic factors link plasma cell lifespan to Ig secretion. Here we show that in the late phases of plasmacytic differentiation, when antibody production becomes maximal, proteasomal activity decreases. The excessive load for the reduced proteolytic capacity correlates with accumulation of polyubiquitinated proteins, stabilization of endogenous proteasomal substrates (including Xbp1s, IkBalpha, and Bax), onset of apoptosis, and sensitization to proteasome inhibitors (PI). These events can be reproduced by expressing Ig-mu chain in nonlymphoid cells. Our results suggest that a developmental program links plasma cell death to protein production, and help explaining the peculiar sensitivity of normal and malignant plasma cells to PI.
2006
Sogg. privati ital. no profit
LS1_5 Protein synthesis, modification and turnover
LS3_5 Cell differentiation, physiology and dynamics
LS6_2 Adaptive immunity
Sì, ma tipo non specificato
Inglese
Internazionale
25
1104
1113
10
MIUR (compresi PRIN FIRB,FISR)
16
info:eu-repo/semantics/article
262
Cenci, S; Mezghrani, A; Cascio, P; Bianchi, G; Cerruti, F; Fra, Annamaria; Lelouard, H; Masciarelli, S; Mattioli, L; Oliva, L; Orsi, A; Pasqualetto, E...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
reserved
File in questo prodotto:
File Dimensione Formato  
Embo J-Progressively proteasomal.pdf

gestori archivio

Tipologia: Full Text
Licenza: DRM non definito
Dimensione 249.59 kB
Formato Adobe PDF
249.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/23735
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 144
  • ???jsp.display-item.citation.isi??? 142
social impact